57 related articles for article (PubMed ID: 15539806)
21. Management of recombinant human growth hormone therapy at puberty.
Albers N
Horm Res; 1998; 49 Suppl 2():58-61. PubMed ID: 9730673
[TBL] [Abstract][Full Text] [Related]
22. Cortical bone density is normal in prepubertal children with growth hormone (GH) deficiency, but initially decreases during gh replacement due to early bone remodeling.
Baroncelli GI; Bertelloni S; Galli L; Sodini F; Saggese G
J Clin Endocrinol Metab; 2004 May; 89(5):2505; author reply 2505-6. PubMed ID: 15126585
[No Abstract] [Full Text] [Related]
23. Multicentre survey on compliance with growth hormone therapy: what can be improved?
Oyarzabal M; Aliaga M; Chueca M; Echarte G; Ulied A
Acta Paediatr; 1998 Apr; 87(4):387-91. PubMed ID: 9628292
[TBL] [Abstract][Full Text] [Related]
24. Compliance with growth hormone treatment--are they getting it?
Smith SL; Hindmarsh PC; Brook CG
Arch Dis Child; 1993 Jan; 68(1):91-3. PubMed ID: 8435018
[TBL] [Abstract][Full Text] [Related]
25. Patient knowledge and compliance with growth hormone treatment.
Stanhope R; Moyle L; MacSwiney M
Arch Dis Child; 1993 Apr; 68(4):525. PubMed ID: 8503683
[No Abstract] [Full Text] [Related]
26. Compliance with growth hormone treatment--are they getting it?
Smith SL; Hindmarsh PC; Brook CG
Arch Dis Child; 1995 Sep; 73(3):277. PubMed ID: 7492183
[No Abstract] [Full Text] [Related]
27. Non-compliance with growth hormone treatment in children is common and impairs linear growth.
Cutfield WS; Derraik JG; Gunn AJ; Reid K; Delany T; Robinson E; Hofman PL
PLoS One; 2011 Jan; 6(1):e16223. PubMed ID: 21305004
[TBL] [Abstract][Full Text] [Related]
28. Treatment Adherence to Injectable Treatments in Pediatric Growth Hormone Deficiency Compared With Injectable Treatments in Other Chronic Pediatric Conditions: A Systematic Literature Review.
Gomez R; Ahmed SF; Maghnie M; Li D; Tanaka T; Miller BS
Front Endocrinol (Lausanne); 2022; 13():795224. PubMed ID: 35299969
[TBL] [Abstract][Full Text] [Related]
29. Switching to Weekly Lonapegsomatropin from Daily Somatropin in Children with Growth Hormone Deficiency: The fliGHt Trial.
Maniatis AK; Nadgir U; Saenger P; Reifschneider KL; Abuzzahab J; Deeb L; Fox LA; Woods KA; Song W; Mao M; Chessler SD; Komirenko AS; Shu AD; Casella SJ; Thornton PS
Horm Res Paediatr; 2022; 95(3):233-243. PubMed ID: 35263755
[TBL] [Abstract][Full Text] [Related]
30. COMPLIA: A 12-MONTH PROSPECTIVE, MULTICENTRE, NON-INTERVENTIONAL STUDY TO EVALUATE TREATMENT ADHERENCE AND TREATMENT SATISFACTION IN A GROWTH HORMONE DEFICIENT PAEDIATRIC POPULATION TREATED WITH NUTROPINAQ
Dumitrescu CP; Procopiuc C; Dumitriu N; Micle I; Anton M; Moisuc A
Acta Endocrinol (Buchar); 2020; 16(2):192-198. PubMed ID: 33029236
[TBL] [Abstract][Full Text] [Related]
31. Shared Decision-Making in Growth Hormone Therapy-Implications for Patient Care.
Acerini CL; Segal D; Criseno S; Takasawa K; Nedjatian N; Röhrich S; Maghnie M
Front Endocrinol (Lausanne); 2018; 9():688. PubMed ID: 30524377
[TBL] [Abstract][Full Text] [Related]
32. Is insulin-like growth factor-1 monitoring useful in assessing the response to growth hormone of growth hormone-deficient children?
Lanes R; Jakubowicz S
J Pediatr; 2002 Nov; 141(5):606-10. PubMed ID: 12410186
[TBL] [Abstract][Full Text] [Related]
33. Cardiovascular effects of growth hormone treatment: potential risks and benefits.
Colao A
Horm Res; 2004; 62 Suppl 3():42-50. PubMed ID: 15539798
[TBL] [Abstract][Full Text] [Related]
34. Stepping into adulthood: the transition period.
Shalet S
Horm Res; 2004; 62 Suppl 4():15-22. PubMed ID: 15591762
[TBL] [Abstract][Full Text] [Related]
35. Optimizing growth hormone efficacy: an evidence-based analysis.
Lustig RH
Horm Res; 2004; 62 Suppl 3():93-7. PubMed ID: 15539806
[TBL] [Abstract][Full Text] [Related]
36. Adult height in patients treated for isolated growth hormone deficiency: role of birth weight.
Di Cesare Merlone A; Bozzola E; Castelnovi C; Chiabotto P; Costante L; De Sanctis L; Tinelli C; Bozzola M
Horm Res; 2005; 63(2):102-6. PubMed ID: 15767761
[TBL] [Abstract][Full Text] [Related]
37. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
Ranke MB; Traunecker R; Martin DD; Schweizer R; Schwarze CP; Wollmann HA; Binder G
Horm Res; 2005; 64(2):68-76. PubMed ID: 16113581
[TBL] [Abstract][Full Text] [Related]
38.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
39.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
40.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
